Cost effectiveness and cost utility analyses of finasteride therapy for the treatment of benign prostatic hyperplasia - systematic review
Baladi JF, Menon D
Record Status
This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Citation
Baladi JF, Menon D. Cost effectiveness and cost utility analyses of finasteride therapy for the treatment of benign prostatic hyperplasia - systematic review. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA). 1995
Authors' objectives
To examine the cost-effectiveness of finasteride therapy in the treatment of benign prostatic hyperplasia in Canadian provinces.
Authors' conclusions
There is an economic/clinical argument for including finasteride in provincial drug plan formularies for a specific category of patient defined by its symptom severity and the time horizon involved in the drug therapy.